Regulatory immune cells in regulation of intestinal inflammatory response to microbiota

M. Sun, C. He, Yingzi Cong, Z. Liu

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

The intestinal lumen harbors nearly 100 trillion commensal bacteria that exert crucial function for health. An elaborate balance between immune responses and tolerance to intestinal microbiota is required to maintain intestinal homeostasis. This process depends on diverse regulatory mechanisms, including both innate and adaptive immunity. Dysregulation of the homeostasis between intestinal immune systems and microbiota has been shown to be associated with the development of inflammatory bowel diseases (IBD) in genetically susceptible populations. In this review, we discuss the recent progress reported in studies of distinct types of regulatory immune cells in the gut, including intestinal intraepithelial lymphocytes, Foxp3 + regulatory T cells, regulatory B cells, alternatively activated macrophages, dendritic cells, and innate lymphoid cells, and how dysfunction of this immune regulatory system contributes to intestinal diseases such as IBD. Moreover, we discuss the manipulation of these regulatory immune cells as a potential therapeutic method for management of intestinal inflammatory disorders.

Original languageEnglish (US)
Pages (from-to)969-978
Number of pages10
JournalMucosal Immunology
Volume8
Issue number5
DOIs
StatePublished - Sep 19 2015

Fingerprint

Microbiota
Inflammatory Bowel Diseases
Immune System
Regulatory B-Lymphocytes
Homeostasis
Lymphocytes
Intestinal Diseases
Immune Tolerance
Adaptive Immunity
Regulatory T-Lymphocytes
Innate Immunity
Dendritic Cells
Macrophages
Bacteria
Health
Population
Therapeutics
Gastrointestinal Microbiome

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. / Sun, M.; He, C.; Cong, Yingzi; Liu, Z.

In: Mucosal Immunology, Vol. 8, No. 5, 19.09.2015, p. 969-978.

Research output: Contribution to journalArticle

@article{11ba73faa57f4b1d98c6262f232cc53f,
title = "Regulatory immune cells in regulation of intestinal inflammatory response to microbiota",
abstract = "The intestinal lumen harbors nearly 100 trillion commensal bacteria that exert crucial function for health. An elaborate balance between immune responses and tolerance to intestinal microbiota is required to maintain intestinal homeostasis. This process depends on diverse regulatory mechanisms, including both innate and adaptive immunity. Dysregulation of the homeostasis between intestinal immune systems and microbiota has been shown to be associated with the development of inflammatory bowel diseases (IBD) in genetically susceptible populations. In this review, we discuss the recent progress reported in studies of distinct types of regulatory immune cells in the gut, including intestinal intraepithelial lymphocytes, Foxp3 + regulatory T cells, regulatory B cells, alternatively activated macrophages, dendritic cells, and innate lymphoid cells, and how dysfunction of this immune regulatory system contributes to intestinal diseases such as IBD. Moreover, we discuss the manipulation of these regulatory immune cells as a potential therapeutic method for management of intestinal inflammatory disorders.",
author = "M. Sun and C. He and Yingzi Cong and Z. Liu",
year = "2015",
month = "9",
day = "19",
doi = "10.1038/mi.2015.49",
language = "English (US)",
volume = "8",
pages = "969--978",
journal = "Mucosal Immunology",
issn = "1933-0219",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Regulatory immune cells in regulation of intestinal inflammatory response to microbiota

AU - Sun, M.

AU - He, C.

AU - Cong, Yingzi

AU - Liu, Z.

PY - 2015/9/19

Y1 - 2015/9/19

N2 - The intestinal lumen harbors nearly 100 trillion commensal bacteria that exert crucial function for health. An elaborate balance between immune responses and tolerance to intestinal microbiota is required to maintain intestinal homeostasis. This process depends on diverse regulatory mechanisms, including both innate and adaptive immunity. Dysregulation of the homeostasis between intestinal immune systems and microbiota has been shown to be associated with the development of inflammatory bowel diseases (IBD) in genetically susceptible populations. In this review, we discuss the recent progress reported in studies of distinct types of regulatory immune cells in the gut, including intestinal intraepithelial lymphocytes, Foxp3 + regulatory T cells, regulatory B cells, alternatively activated macrophages, dendritic cells, and innate lymphoid cells, and how dysfunction of this immune regulatory system contributes to intestinal diseases such as IBD. Moreover, we discuss the manipulation of these regulatory immune cells as a potential therapeutic method for management of intestinal inflammatory disorders.

AB - The intestinal lumen harbors nearly 100 trillion commensal bacteria that exert crucial function for health. An elaborate balance between immune responses and tolerance to intestinal microbiota is required to maintain intestinal homeostasis. This process depends on diverse regulatory mechanisms, including both innate and adaptive immunity. Dysregulation of the homeostasis between intestinal immune systems and microbiota has been shown to be associated with the development of inflammatory bowel diseases (IBD) in genetically susceptible populations. In this review, we discuss the recent progress reported in studies of distinct types of regulatory immune cells in the gut, including intestinal intraepithelial lymphocytes, Foxp3 + regulatory T cells, regulatory B cells, alternatively activated macrophages, dendritic cells, and innate lymphoid cells, and how dysfunction of this immune regulatory system contributes to intestinal diseases such as IBD. Moreover, we discuss the manipulation of these regulatory immune cells as a potential therapeutic method for management of intestinal inflammatory disorders.

UR - http://www.scopus.com/inward/record.url?scp=84939478859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939478859&partnerID=8YFLogxK

U2 - 10.1038/mi.2015.49

DO - 10.1038/mi.2015.49

M3 - Article

VL - 8

SP - 969

EP - 978

JO - Mucosal Immunology

JF - Mucosal Immunology

SN - 1933-0219

IS - 5

ER -